🇺🇸 FDA
Patent

US 11034933

Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection

granted A61KA61K39/21A61K40/11

Quick answer

US patent 11034933 (Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection) held by The Regents of the University of California expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K39/21, A61K40/11, A61K40/31, A61K40/46